NASDAQ: IRIX
Iridex Corp Stock Ownership - Who owns Iridex?

Insider buying vs selling

Have Iridex Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Patrick MercerPresident and CEO2026-06-133,990$1.12
$4.47kSell
Romeo R. DizonChief Financial Officer2026-06-132,691$1.12
$3.01kSell
Romeo R. DizonChief Financial Officer2026-06-12975$1.14
$1.11kBuy
Romeo R. DizonChief Financial Officer2026-06-111,675$1.14
$1.91kBuy
Romeo R. DizonChief Financial Officer2026-06-082,400$1.12
$2.69kBuy
Romeo R. DizonChief Financial Officer2026-06-052,521$1.15
$2.90kBuy
Romeo R. DizonChief Financial Officer2026-06-032,400$1.17
$2.81kBuy
Patrick MercerPresident and CEO2026-05-2619,233$1.01
$19.43kSell
Romeo R. DizonChief Financial Officer2026-05-265,004$1.00
$5.00kBuy
Romeo R. DizonChief Financial Officer2026-03-061,110$1.26
$1.40kBuy

1 of 9

IRIX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IRIX insiders and whales buy or sell their stock.

IRIX Shareholders

What type of owners hold Iridex Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blueline Catalyst Fund IX LP14.70%2,559,122$2.89MInsider
Blueline Capital Partners II LP14.41%2,508,100$2.83MInsider
Blueline Partners LLC 114.27%2,483,815$2.81MInsider
Blueline Partners LLC14.16%2,465,222$2.79MInsider
Scott Shuda10.05%1,750,059$1.98MInsider
Topcon America Corp9.30%1,618,122$1.83MInsider
Associates Paragon Associates Ii Joint Venture Paragon7.58%1,320,000$1.49MInsider
Acuta Capital Fund LP6.65%1,157,011$1.31MInsider
Blueline Capital Partners LP6.54%1,138,862$1.29MInsider
Paragon Associates Paragon Associates II Joint Venture5.74%1,000,000$1.13MInstitution

1 of 3

IRIX vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IRIX12.66%87.34%Net BuyingNet Selling
LFWD0.05%99.95%Net Selling
HIND0.41%99.59%
AIMD0.81%99.19%Net BuyingNet Buying
CTSO26.23%45.80%Net BuyingNet Buying

Iridex Stock Ownership FAQ

Who owns Iridex?

Iridex (NASDAQ: IRIX) is owned by 16.61% institutional shareholders, 114.61% Iridex insiders, and 0.00% retail investors. Blueline Catalyst Fund IX LP is the largest individual Iridex shareholder, owning 2.56M shares representing 14.70% of the company. Blueline Catalyst Fund IX LP's Iridex shares are currently valued at $2.89M.

If you're new to stock investing, here's how to buy Iridex stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.